Cargando…

Single nucleotide polymorphism leads to daptomycin resistance causing amino acid substitution—T345I in MprF of clinically isolated MRSA strains

Daptomycin (DAP) is one of the most potent antibiotics used for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. Due to an increase in its administration for combating MRSA infections, DAP non-susceptible (DAP-NS) MRSA strains have recently been reported in clinical se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Masaki, Kawada, Hayato, Uchida, Hiroki, Takagi, Yusuke, Obata, Shuichi, Eda, Ryotaro, Hanaki, Hideaki, Kitasato, Hidero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822245/ https://www.ncbi.nlm.nih.gov/pubmed/33481910 http://dx.doi.org/10.1371/journal.pone.0245732

Ejemplares similares

Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
por: Chen, Feng-Jui, et al.
Publicado: (2018)

Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA)
por: Thitiananpakorn, Kanate, et al.
Publicado: (2020)

Role of mprF1 and mprF2 in the Pathogenicity of Enterococcus faecalis
por: Bao, Yinyin, et al.
Publicado: (2012)

Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance
por: Ernst, Christoph M., et al.
Publicado: (2018)

Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity
por: Steed, Molly E., et al.
Publicado: (2013)

Daptomycin Resistant Staphylococcus aureus Clinical Strain With Novel Non-synonymous Mutations in the mprF and vraS Genes: A New Insight Into Daptomycin Resistance
por: Sabat, Artur J., et al.
Publicado: (2018)

Insights into the Roles of Lipoteichoic Acids and MprF in Bacillus subtilis
por: Guyet, Aurélie, et al.
Publicado: (2023)

Phenotypic and Genotypic Characterization of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Strains: Relative Roles of mprF and dlt Operons
por: Mishra, Nagendra N., et al.
Publicado: (2014)

Phospholipid translocation captured in a bifunctional membrane protein MprF
por: Song, Danfeng, et al.
Publicado: (2021)

Emergence of Daptomycin Resistance in Daptomycin-Naïve Rabbits with Methicillin-Resistant Staphylococcus aureus Prosthetic Joint Infection Is Associated with Resistance to Host Defense Cationic Peptides and mprF Polymorphisms
por: Mishra, Nagendra N., et al.
Publicado: (2013)

Too Much or Not Enough: The Role of mprF in Regulating Overall Phospholipid Content
por: Fozo, Elizabeth M.
Publicado: (2023)

Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF
por: Slavetinsky, Christoph J, et al.
Publicado: (2022)

The MprF homolog LysX synthesizes lysyl-diacylglycerol contributing to antibiotic resistance and virulence
por: Gill, Cameron P., et al.
Publicado: (2023)

LysX2 is a Mycobacterium tuberculosis membrane protein with an extracytoplasmic MprF-like domain
por: Boldrin, Francesca, et al.
Publicado: (2022)

The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion
por: Ernst, Christoph M., et al.
Publicado: (2009)

Characterization of the IncFII-IncFIB(pB171) Plasmid Carrying bla(NDM-5) in Escherichia coli ST405 Clinical Isolate in Japan
por: Takayama, Yoko, et al.
Publicado: (2020)

Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012)

Rejection and killing, without MPR
por: Dove, Alan W.
Publicado: (2003)

Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
por: Shaw, E, et al.
Publicado: (2015)

Genome Sequence of Acinetobacter towneri Strain DSM 16313, Previously Known as the Proposed Type Strain of Acinetobacter seohaensis
por: Maehana, Shotaro, et al.
Publicado: (2021)

Observation of “Seesaw Effect” with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
por: Barber, Katie E., et al.
Publicado: (2014)

Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost
por: Roch, Melanie, et al.
Publicado: (2017)

711. Molecular Epidemiology of Daptomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
por: Sundaram, Ayesha, et al.
Publicado: (2018)

The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
por: Morrisette, Taylor, et al.
Publicado: (2020)

1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018)

Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection
por: Barlow, Ashley, et al.
Publicado: (2021)

Successful Treatment With Daptomycin of MRSA Empyema Complicated by Right-Sided Loculated Pleural Effusion Refractory to Vancomycin
por: Torjani, Ava, et al.
Publicado: (2022)

Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts
por: Kusunoki, Natsuko, et al.
Publicado: (2004)

Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSA
por: Valente, Luca G., et al.
Publicado: (2021)

Decoding phage resistance by mpr and its role in survivability of Mycobacterium smegmatis
por: Seniya, Surya Pratap, et al.
Publicado: (2022)

Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach
por: Garonzik, Samira M., et al.
Publicado: (2016)

1399. Efficacy of Daptomycin Combination with β-Lactams for Daptomycin-resistant Enterococcus faecium Harboring LiaSR Substitutions
por: Kebriaei, Razieh, et al.
Publicado: (2018)

Expression and Purification of Human Membrane Progestin Receptor α (mPRα)
por: Hossain, Md. Babul, et al.
Publicado: (2015)

mPR-Specific Actions Influence Maintenance of the Blood–Brain Barrier (BBB)
por: Abou-Fadel, Johnathan, et al.
Publicado: (2022)

Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
por: McCreary, Erin K, et al.
Publicado: (2019)

1624. Real World Experience with Daptomycin (DAP) and Ceftaroline (CPT) Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia
por: Zidaru, Andrei, et al.
Publicado: (2020)

Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
por: Husain, Afzal, et al.
Publicado: (2018)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

2403. Comparison of Daptomycin Combination Therapy With Ceftaroline or Oxacillin Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Causing Persistent Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018)

Multiple Primary Recurrent Basaliomas (mPR-BCCs) of the Scalp with Cranial Bone Invasion
por: Tchernev, Georgi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_00q8ot5dedf9lh1omvob1jnimv